{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:28:20Z","timestamp":1791890900740,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/s11864-005-0046-6","type":"journal-article","created":{"date-parts":[[2007,7,4]],"date-time":"2007-07-04T18:52:03Z","timestamp":1183575123000},"page":"437-445","source":"Crossref","is-referenced-by-count":62,"title":["Management strategies for patients with hereditary pancreatic cancer"],"prefix":"10.1007","volume":"6","author":[{"given":"Teresa A.","family":"Brentnall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"46_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/canjclin.53.1.5","volume":"53","author":"A Jemal","year":"2003","unstructured":"Jemal A, Murray T, Samuels A, et al.: Cancer statistics, 2003. CA Cancer J Clin 2003, 53:5\u201326.","journal-title":"CA Cancer J Clin"},{"key":"46_CR2","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.biocel.2004.02.010","volume":"36","author":"SJ Rulyak","year":"2004","unstructured":"Rulyak SJ, Kimmey MB, Brentnall T: Inherited Pancreatic Cancer: Improvements in our understanding of genetics and screening. Int J Biochem Cell Biol 2004, 36:1386\u20131392.","journal-title":"Int J Biochem Cell Biol"},{"key":"46_CR3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-131-4-199908170-00003","volume":"131","author":"TA Brentnall","year":"1999","unstructured":"Brentnall TA, Bronner MP, Byrd DR, et al: Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 1999, 131:247\u2013255. This is the seminal paper describing the first surveillance program for pancreatic cancer in high-risk individuals.","journal-title":"Ann Intern Med"},{"issue":"Suppl 4","key":"46_CR4","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1093\/annonc\/10.suppl_4.S69","volume":"10","author":"RH Hruban","year":"1999","unstructured":"Hruban RH, Petersen GM, Tersmette AC, et al.: Familial pancreatic cancer. Ann Onc 1999, 10(Suppl 4):S69-S73.","journal-title":"Ann Onc"},{"key":"46_CR5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/gut.48.2.143","volume":"48","author":"E Efthimou","year":"2001","unstructured":"Efthimou E, Crnogorac-Jurcevic T, Lemoine NR, Brentnall TA: Inherited predisposition to pancreatic cancer. Gut 2001, 48:143\u2013147.","journal-title":"Gut"},{"key":"46_CR6","first-page":"409","volume":"60","author":"G Lal","year":"2000","unstructured":"Lal G, Liu G, Schmocker B, et al: Inherited predisposition to pancreatic adenocarcinoma: role of family history and germline pl6, BRCA1, and BRCA2 mutations. Cancer Res 2000, 60:409\u2013416.","journal-title":"Cancer Res"},{"key":"46_CR7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1098-2264(200004)27:4<358::AID-GCC4>3.0.CO;2-O","volume":"27","author":"G Lal","year":"2000","unstructured":"Lal G, Liu L, Hogg D, et al: Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations. Genes Chromosomes Cancer 2000, 27:358\u201361.","journal-title":"Genes Chromosomes Cancer"},{"key":"46_CR8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/gepi.1102","volume":"23","author":"AP Klein","year":"2002","unstructured":"Klein AP, BeatyTH, Bailey-Wilson JE,et al: Evidence for a major gene influencing risk of pancreatic cancer. Genet Epidemiol 2002, 23:133\u2013149.","journal-title":"Genet Epidemiol"},{"key":"46_CR9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0025-7125(05)70250-9","volume":"84","author":"MG Banke","year":"2000","unstructured":"Banke MG, Mulvihill JJ, Aston CE: Inheritance of pancreatic cancer in pancreatic cancerprone families. Med Clin North Am 2000, 84:677\u2013690.","journal-title":"Med Clin North Am"},{"key":"46_CR10","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/339692","volume":"70","author":"MA Eberle","year":"2002","unstructured":"Eberle MA, Pf\u00fctzer R, Pogue-Geile KL, et al: A new sus-ceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32\u201334. Amer J Human Genetics 2002, 70:1044\u20131048.","journal-title":"Amer J Human Genetics"},{"key":"46_CR11","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/cncr.11562","volume":"98","author":"SJ Rulyak","year":"2003","unstructured":"Rulyak SJ, Brentnall TA, Lynch HT, Austin MA: Characterization of the neoplastic phenotype in the familial atypical multiplemole melanoma-pancreatic carcinoma syndrome. Cancer 2003, 98:798\u2013804.","journal-title":"Cancer"},{"key":"46_CR12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0025-7125(05)70253-4","volume":"84","author":"TA Brentnall","year":"2000","unstructured":"Brentnall TA: Cancer surveillance of patients from familial pancreatic cancer kindreds. Med Clin North Am 2000, 84:707\u2013718.","journal-title":"Med Clin North Am"},{"key":"46_CR13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1159\/000055851","volume":"1","author":"SJ Rulyak","year":"2001","unstructured":"Rulyak SJ, Brentnall TA: Inherited Pancreatic Cancer: Surveillance and treatment strategies for affected families. Pancreatology 2001, 1:477\u2013485.","journal-title":"Pancreatology"},{"key":"46_CR14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mge.2003.28","volume":"57","author":"SJ Rulyak","year":"2003","unstructured":"Rulyak SJ, Kimmey MB, Veenstra D, Brentnall TA: Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds. Gastrointest Endosc 2003, 57:23\u201329.","journal-title":"Gastrointest Endosc"},{"key":"46_CR15","first-page":"738","volume":"7","author":"AC Tersmette","year":"2001","unstructured":"Tersmette AC, Petersen GM, Offerhaus GJ, et al: Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res 2001, 7:738\u2013734.","journal-title":"Clin Cancer Res"},{"key":"46_CR16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00000478-200105000-00003","volume":"25","author":"RH Hruban","year":"2001","unstructured":"Hruban RH, Adsay NV, Albores-Saavedra J, et al: Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001, 25:579\u2013586. This landmark paper derives the pathologic findings and nomenclature that will describe the precancerous lesions of pancreatic adenocarcinoma.","journal-title":"Am J Surg Pathol"},{"key":"46_CR17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000478-199802000-00003","volume":"22","author":"DJ Brat","year":"1998","unstructured":"Brat DJ, Lillemoe KD, Yeo CJ, et al: Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Path 1998, 22:163\u2013169.","journal-title":"Am J Surg Path"},{"key":"46_CR18","first-page":"2969","volume":"6","author":"RH Hruban","year":"2000","unstructured":"Hruban RH, Goggins M, Parsons J, Kern SE: Progression model for pancreatic cancer. Clin Cancer Res 2000, 6:2969\u20132972. This is the primer that describes the phenotype and underlying genetic abnormalities that lead to neoplastic progression in pancreatic cancer.","journal-title":"Clin Cancer Res"},{"key":"46_CR19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","volume":"4","author":"SR Hingorani","year":"2003","unstructured":"Hingorani SR, Petricoin EF, Maitra A, et al.: Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003, 4:437\u2013450.","journal-title":"Cancer Cell"},{"key":"46_CR20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/MCB.22.2.635-643.2002","volume":"22","author":"N Bardeesy","year":"2002","unstructured":"Bardeesy N, Morgan J, Sinha M, et al.: Obligate roles for pl6(Ink4a) and pl9(Arf)-p53 in the suppression of murine pancreatic neoplasia. Mol Cell Biol 2002, 22:635\u2013643.","journal-title":"Mol Cell Biol"},{"key":"46_CR21","first-page":"1047","volume":"25","author":"KA Meckler","year":"2001","unstructured":"Meckler KA, Brentnall TA, Haggitt RC, et al.: Familial fibrocystic pancreatic atrophy with endocrine cell hyperplasia and pancreatic carcinoma. Am J Surg Va.th.tl 2001, 25:1047\u20131053.","journal-title":"Am J Surg Va.th.tl"},{"key":"46_CR22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00006676-200311000-00014","volume":"27","author":"RJ Hine","year":"2003","unstructured":"Hine RJ, Srivastava S, Milner JA, Ross SA: Nutritional links to plausible mechanisms underlying pancreatic cancer: a conference report. Pancreas 2003, 27:356\u2013366.","journal-title":"Pancreas"},{"key":"46_CR23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/aje\/kwh214","volume":"160","author":"HG Skinner","year":"2004","unstructured":"Skinner HG, Michaud DS, Giovannucd EL, et al.: A pro-spective study of folate intake and the risk of pancreatic cancer in men and women. Am J Epidemiol 2004, 160:248\u2013258.","journal-title":"Am J Epidemiol"},{"key":"46_CR24","first-page":"314","volume":"57","author":"YI Kim","year":"1999","unstructured":"Kim YI: Folate and cancer prevention: a new medical application of folate beyond hyperhomocysteinemia and neural tube defects. Nutr Rev 1999, 57:314\u2013321.","journal-title":"Nutr Rev"},{"key":"46_CR25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s002680020344","volume":"25","author":"WE Fisher","year":"2001","unstructured":"Fisher WE: Diabetes: risk factor for the development of pancreatic cancer or manifestation of the disease? World J Surg 2001, 25:503\u2013508.","journal-title":"World J Surg"},{"key":"46_CR26","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/sj.bjc.6690607","volume":"80","author":"DT Silverman","year":"1999","unstructured":"Silverman DT, Schiffman M, Everhart J, et al: Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 1999, 80:1830\u20131837.","journal-title":"Br J Cancer"},{"key":"46_CR27","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0016-5085(03)00272-5","volume":"124","author":"SJ Rulyak","year":"2003","unstructured":"Rulyak SJ, Lowenfels AB, Maisonneuve P, Brentnall TA: Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology 2003, 124:1291\u20131299. This paper describes the risk factors for the development of pancreatic cancer in families who inherit the disease.","journal-title":"Gastroenterology"},{"key":"46_CR28","first-page":"119","volume":"9","author":"PF Coogan","year":"2000","unstructured":"Coogan PF, Rosenberg L, Palmer JR, et al: Nonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowel. Cancer Epidemiol Biomarkers Prev 2000, 9:119\u201323.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"46_CR29","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/(SICI)1097-0274(199908)36:2<260::AID-AJIM5>3.0.CO;2-P","volume":"36","author":"GJ Kernan","year":"1999","unstructured":"Kernan GJ, Ji BT, Dosemeci M, et al: Occupational risk factors for pancreatic cancer: a case-control study based on death certificates from 24 U.S. states. Am J IndMed 1999, 36:260\u2013270.","journal-title":"Am J IndMed"},{"key":"46_CR30","first-page":"199","volume":"9","author":"JA Hoppin","year":"2000","unstructured":"Hoppin JA, Tolbert PE, Holly EA, et al: Pancreatic can-cer and serum organochlorine levels. Cancer Epidemiol Biomarkers Prev 2000, 9:199\u2013205.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"46_CR31","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1002\/cncr.20700","volume":"101","author":"TA James","year":"2004","unstructured":"James TA, Sheldon DG, Rajput A, et al: Risk factors associated with earlier age of onset in familial pancreatic carcinoma. Cancer 2004, 101:2722\u20132726.","journal-title":"Cancer"},{"key":"46_CR32","first-page":"429","volume":"10","author":"DS Michaud","year":"2001","unstructured":"Michaud DS, Giovannucci E, Willett WC, et al: Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts. Cancer Epidemiol Biomarkers Prev 2001, 10:429\u2013437.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"46_CR33","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/S0016-5107(02)70092-8","volume":"56","author":"MB Kimmey","year":"2002","unstructured":"Kimmey MB, Brentnall TA, Bronner MP, Byrd DR: Endoscopic ultrasound screening for familial pancreatic cancer. Gastrointest Endosc 2002, 56:S82-S86.","journal-title":"Gastrointest Endosc"},{"key":"46_CR34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1399-0012.2004.00110.x","volume":"18","author":"KP Charpentier","year":"2004","unstructured":"Charpentier KP, Brentnall TA, Bronner MP, et al: A new indication for pancreas transplantation: high grade pancreatic dysplasia. Clin Transplant 2004, 18:105\u2013107.","journal-title":"Clin Transplant"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-005-0046-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-005-0046-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-005-0046-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:34:14Z","timestamp":1559432054000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-005-0046-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["46"],"URL":"https:\/\/doi.org\/10.1007\/s11864-005-0046-6","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}